Temozolomide Cocrystals with Carboxamide Coformers
Authors:
- 19 April 2013
- journal article
- research article
- Published by American Chemical Society (ACS) in Crystal Growth & Design
- Vol. 13 (5) , 2208-2219
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Temozolomide hydrochloride dihydrateCrystEngComm, 2012
- Pharmaceutical Cocrystals of NiclosamideCrystal Growth & Design, 2012
- Crystal Engineering of Stable Temozolomide CocrystalsChemistry – An Asian Journal, 2012
- A Tale of Two Polymorphic Pharmaceuticals: Pyrithyldione and Propyphenazone and their 1937 Co‐crystal PatentChemistry – A European Journal, 2011
- Synthon polymorphism and pseudopolymorphism in co-crystals. The 4,4′-bipyridine–4-hydroxybenzoic acid structural landscapeChemical Communications, 2011
- OLEX2: a complete structure solution, refinement and analysis programJournal of Applied Crystallography, 2009
- Polymorphism in Carbamazepine CocrystalsCrystal Growth & Design, 2008
- Pharmaceutical Co-CrystalsJournal of Pharmaceutical Sciences, 2006
- Supramolecular synthons based on N–H⋯N and C–H⋯O hydrogen bonds. Crystal engineering of a helical structure with 5,5-diethylbarbituric acidChemical Communications, 2002
- Antitumor imidazotetrazines. 25. Crystal structure of 8-carbamoyl-3-methylimidazo[5,1-d]-1,2,3,5-tetrazin-4(3H)-one (temozolomide) and structural comparisons with the related drugs mitozolomide and DTICJournal of Medicinal Chemistry, 1992